| Literature DB >> 29404008 |
Pradeepa Krishnappa1,2, Krishna Venkatarangaiah1, Santosh Kumar Shimoga Rajanna1, Rebijith Kayattukandy Balan3.
Abstract
Delonix elata L. is a Ceasalpinaceae species and is traditionally used in India for treatment of skin diseases, liver diseases and rheumatic problems. However, systematic evaluation of its wound healing activity is lacking. Thus, in the present study, we aimed to assess the wound healing activity of D. elata stem bark extract (DSE) and its isolated constituent quercetin-3-rhamnopyranosyl-(1-6) glucopyranoside (QRPG) in rats. The formulations effects on wound healing were assessed by the wound contraction rate, epithelialization period, tensile strength, content of the hydroxyproline, hexosamine and uronic acid in granulation tissue, histopathological studies and Col 1 α (I) expression level in wound tissue by reverse transcription polymerase chain reaction (RT-PCR) study. The topical application of DSE ointment caused faster epithelialization, significant wound contraction (100%), and better tensile strength (710.5±10.5 g/cm2), while QRPG showed wound epithelialization with 98.2% contraction, better than that of the control group (78.18%). The biochemical analysis of granulation tissue revealed that DSE and QRPG significantly increased hydroxyproline, hexosamine and uronic acid content. A significant increase in the expression of Col 1 α (I) was observed in the wound tissue of DSE and QRPG treated rats. DSE and QRPG were shown to enhance wound healing by increasing collagen synthesis through up-regulation of Col 1 α (I), thus validating ethnomedicinal uses.Entities:
Keywords: Delonix elata; Hydroxyproline; Quercetin-3-rhamnopyranosyl-(1-6) glucopyranoside (QRPG); Tensile strength; Wound healing
Year: 2016 PMID: 29404008 PMCID: PMC5762931 DOI: 10.1016/j.jpha.2016.05.001
Source DB: PubMed Journal: J Pharm Anal ISSN: 2214-0883
13C NMR spectral data of QRPG.
| Carbon position | Signal ( | Carbon position | Signal ( |
|---|---|---|---|
| 1 | |||
| 2 | 157.48 | 1″ | 101.28 |
| 3 | 113.72 | 2″ | 70.82 |
| 4 | 181.91 | 3″ | |
| 5 | 163.33 | 4″ | 70.24 |
| 6 | 99.08 | 5″ | 68.65 |
| 7 | 164.42 | 6″ | 66.73 |
| 8 | 94.26 | 1′″ | 100.80 |
| 9 | 160.00 | 2′″ | 73.34 |
| 10 | 104.13 | 3′″ | 75.93 |
| 1′ | 124.91 | 4′″ | 71.71 |
| 2′ | 116.09 | 5′″ | 71.08 |
| 3′ | 148.58 | 6′″ | 18.02 |
| 4′ | 146.98 | ||
| 5′ | 118.65 | ||
| 6′ | 128.31 |
Fig. 1Structure of quercetin-3-rhamnopyranosyl-(1-6) glucopyranoside.
Fig. 2Effect of topical application of DSE and QRPG on the wound area expressed as percentage of wound contraction. Values are expressed as mean±SE of six animals in each group.
Effects of DSE and QRPG on epithelialization time, tensile strength and content of hydroxyproline, hexosamine and uronic acid.
| Parameters | Ointment base (control) | DSE (5.0%, m/m) | QRPG (0.5%, m/m) | 5% povidone-iodine ointment (standard) |
|---|---|---|---|---|
| Epithelialization time (days) | 22±0.25 | 17±0.25 | 18±0.48 | 18±0.29 |
| Tensile strength (g/cm2) | 488±12 | 710.5±10.5 | 668.5±21.5 | 694.5±5.5 |
| Hydroxyproline content (mg/100 mg dry tissue) | 2.84±0.07 | 4.77±0.03 | 4.54±0.1 | 4.76±0.07 |
| Hexosamine content (μg/100 mg dry tissue) | 0.37±0.02 | 0.62±0.01 | 0.61±0.02 | 0.58±0.02 |
| Uronic acid content (μg/100 mg dry tissue) | 0.12±0.01 | 0.24±0.01 | 0.24±0.01 | 0.22±0.01 |
Values are expressed as mean±SE.
P<0.05 as compared to control.
Fig. 3RT-PCR analysis of Col 1 α (I) mRNA expression in 7th day wound tissue of DSE and QRPG treated rats. β-actin was co-amplified as an internal control (Lane 1: 100 bp ladder; Lane 2: DSE treated; Lane 3: control; Lane 4: QRPG treated).
Fig. 4The values were normalized to β-actin expression and represented as Col 1 α (I)/β-actin band intensity for the 7 th day wound tissue. Values are expressed as mean±SE (n=6).
Fig. 5Histological examination showing control, DSE, QRPG and standard reference treated wound tissues on the 10th post-wound day (1. Macrophages; 2. Collagen fibers). (A) Wound tissue of control animals, (B) wound tissue of DSE treated animals, (C) wound tissue of QRPG treated animals, and (D) wound tissue of povidone-iodine ointment treated animals.